Navigation Links
Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
Date:4/14/2008

the preferred partner to continue development, commercialize and market the drug. Isis will transition development responsibility for mipomersen to Genzyme over the next year. In addition to the up-front payment ($150 million for Isis stock at $30 per share and $175 million mipomersen license fee), Isis also has the opportunity to receive from Genzyme up to $825 million in development and regulatory milestone payments plus up to $750 million in commercial milestone payments. Genzyme and Isis will share mipomersen profits. The profit share begins with a 70/30 Genzyme/Isis split and increases linearly to 50/50 when revenue reaches $2 billion.

Mipomersen is a second-generation antisense drug that reduces the production of apoB-100, a protein critical to the synthesis and transport of "bad" cholesterol. Cholesterol can be carried in the bloodstream in a variety of forms, with high-density lipoprotein, or HDL-cholesterol, being the good form, and low-density lipoproteins, or LDL-cholesterol, and very low-density lipoproteins, or VLDL-cholesterol, being bad forms directly involved in heart disease. Collectively lowering LDL-cholesterol, VLDL-cholesterol, and other bad forms of cholesterol are a key component in the prevention and management of cardiovascular disease.

Currently in Phase 3 development, mipomersen has been shown in Phase 2 trials to reduce cholesterol and other atherogenic lipids more than 40 percent beyond reductions achieved with standard lipid-lowering drugs, enabling more patients to achieve LDL-cholesterol targets. These trials have shown that treatment with mipomersen is well-tolerated, and that mipomersen has an attractive safety profile, and works equally well in the presence and absence of other lipid-lowering therapies including statins. A weekly injectable therapeutic, mipomersen is being developed primarily for patients at high cardiovascular risk who are unable to achieve target cholesterol levels with statins alone or who are into
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
2. Clinical Update - Debio 0614 (Istaroxime) in Acute Heart Failure
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
5. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
6. Anti-Cancer Drug CYT997 Update
7. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
8. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
9. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
10. Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
11. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013  Milliman, Inc., a premier global consulting ... 2013 Milliman Medical Index (MMI), which measures the healthcare ... healthcare benefits through an employer-sponsored preferred provider organization (PPO) ... in 2013 is $22,030. "For the ... on a percentage basis was the lowest in the ...
(Date:5/22/2013)... 2013  Modern Medical announced today the nationwide ... November 2012 in a test phase, ODM is ... the rising opioid abuse in the workers, compensation ... to protect employees, physicians and employers by reducing ... to provide pain relief for the injured worker.  ...
(Date:5/22/2013)... YORK , May 22, 2013 ... LLP is investigating claims on behalf of investors of ... ISRG ) (CUSIP: 46120E602) who purchased Intuitive ... 18, 2013 (the "Class Period"). Such investors are advised ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
Breaking Medicine Technology:Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2
... Feb. 21, 2012  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... King, President and Chief Executive Officer, will present at ... NY and one in Boston, MA, over the coming ...
...   Enanta Pharmaceuticals, Inc. , a research and ... drugs in the infectious disease field, announced today ... and license agreement with Novartis for the worldwide ... candidate, EDP-239, from its NS5A hepatitis C virus ...
Cached Medicine Technology:AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences 2Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 2Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 3
(Date:5/22/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) ... knows there is something about feet that fungi seem ... "map" of the fungal groups that live on your ... hottest neighborhood. It,s no secret that the human ... viruses and fungi, both outside and inside. And it,s ...
(Date:5/22/2013)... York (PRWEB) May 22, 2013 ... of the DePuy Pinnacle Hip Replacement System continue to ... Federal Court, Bernstein Liebhard LLP reports. According to ... DePuy Orthopaedics to produce monitoring reports associated with a ... company’s medical device marketing practices. Plaintiffs maintained in ...
(Date:5/22/2013)... 2013 Today, Zane Benefits, Inc. published ... Exchange . Zane Benefits, which provides comprehensive and flexible ... leader in defined contribution plans and ... website, beginning in 2014 as part of the Affordable ... small businesses will become available through new state health ...
(Date:5/22/2013)... be reaping enormous income for patients whose hospital ... in their intensive care units. , In a ... American Journal of Medical Quality , the researchers ... avoidable central line-associated bloodstream infection (CLABSI) costs nearly ... similar infection-free patient. Moreover, hospitals earn nearly nine ...
(Date:5/22/2013)... May 22, 2013 Registered Dietitian and Founder ... today on Tatalou.com sharing a recipe for making energy bars ... Healthy Energy Bars ,” takes a recipe modified from one ... twists. , “Every day it gets more and more difficult ... said Chevreau. “The size of the nutrition label continues to ...
Breaking Medicine News(10 mins):Health News:Scientists Map the Fungi on Your Feet 2Health News:Scientists Map the Fungi on Your Feet 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:How To "Make Your Own Healthy Energy Bars" 2
... affected by age and imaging capacity the number of ... any given facility, according to a study in the June ... Radiology ( www.jacr.org ). Advanced medical imaging ... are many potential reasons for imaging growth, including that scans ...
... bullies or have conduct problems at school, are more ... University of Michigan Medical School researchers. Researchers looked ... schools who had exhibited conduct problems like bullying or ... higher risk for symptoms of sleep-disordered breathing, particularly daytime ...
... by certain drugs already approved for treating Type II ... tumors. "It,s possible that these diabetes drugs could ... chemotherapeutic drugs, to treat some forms of breast cancer," ... of Pathology and Molecular Medicine and Queen,s University Cancer ...
... May 31 (HealthDay News) -- Violent video games trigger ... new University of Missouri study. Such players showed ... or desensitized, to violence -- a response that the ... perspective, video games are excellent teaching tools because they ...
... , TUESDAY, May 31 (HealthDay News) -- With summer vacation ... healthy eating among their kids, advises the American Dietetic Association ... practical tips to help parents whip up healthy meals that ... that encourages a youthful appreciation for eating well. "For ...
... Americans finds that obese women reported significantly worse health than ... than blacks in the normal or obese weight categories. Respondents ... to their height and weight. The survey results ... Quality of Life Research and they come from ...
Cached Medicine News:Health News:Kids who bully, are aggressive are twice as likely to have sleep problems 2Health News:Diabetic drug could help prevent the spread of cancer 2Health News:Violent Video Games Linked to Increased Aggression 2Health News:Help Your Children Eat Well During Summer Vacation 2Health News:Extra weight equals better health-related quality of life for blacks, not so for women 2
For the quantitative determination of direct & total bilirubin in serum. Modified Malloy-Evelyn Diazotization Method. Endpoint Reaction Product measured at 540 nm. Linearity: 20 mg/dl...
... Powerwave is the first microplate spectrophotometer designed ... 7 days per week. With rugged hardware, ... Powerwave breaks the barrier of traditional spectrophotometry ... One instrument can easily read up to ...
... Spectrophotometers are simple, reliable ... use in many types ... clinical, industrial and environmental ... vial holders, Windows based ...
Spectra 3000RS & Spectra 3000RSP are very precise instruments. They have a metal base structure, durable parts for long life use, and they are very easy to use and maintain....
Medicine Products: